ΔΗΜΟΣΙΕΥΣΕΙΣ
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menendez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez GI, Nowakowski AM, Bornstein J, Munoz N, Bosch FX; Retrospective International Survey and HPV Time Trends Study Group.
Frequent presence of incomplete HPV16 E7 ORFs in lung carcinomas: memories of viral infection
Krikelis D, Tzimagiorgis G, Georgiou E, Destouni C, Agorastos T, Haitoglou C, Kouidou S.
Can HPV testing replace the pap smear?
Agorastos T, Sotiriadis A, Chatzigeorgiou K.
Cervical, uterine corpus, and ovarian cancer mortality in Greece during 1980 to 2005: a trend analysis
Pavlidou E, Zafrakas M, Papadakis N, Benos A, Agorastos T.
Effect of type-specific human papillomavirus incidence on screening performance and cost
Agorastos T, Sotiriadis A, Emmanouilides CJ.
Safety of human papillomavirus (HPV) vaccines: a review of the international experience so far
Agorastos T, Chatzigeorgiou K, Brotherton JM, Garland SM.
